Τρίτη 30 Αυγούστου 2016

Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction

Condition:   Gastroesophageal Junction Adenocarcinoma
Interventions:   Drug: Oxaliplatin; Capecitabine;   Other: Oxaliplatin; Capecitabine; concurrent radiotherapy
Sponsor:   Hebei Medical University
Recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2c5naAg
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου